Abstract

The present invention relates to solid state forms of Lorlatinib and their process for the preparation. Lorlatinib is represented by the following structural formula-1.

Formula-1.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS